SCHEMBL173849

SCHEMBL173849

C=CCCl.CN(C)Cc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.68
ALDH1A1 P00352 1/20 0.68
TAAR1 Q96RJ0 3/20 0.53
AOC3 Q16853 1/20 0.47
HRH3 Q9Y5N1 1/20 0.45
GAA P10253 1/20 0.42
CARM1 Q86X55 1/20 0.41
PRMT6 Q96LA8 1/20 0.41
PRMT8 Q9NR22 1/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
SLC6A2 P23975 1/20 0.40
HTR2A P28223 1/20 0.40
SLC6A4 P31645 1/20 0.40
ADRA1A P35348 1/20 0.40
OPRK1 P41145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL22467854 0.98 ALDH1A1 (0.65) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL1261497 0.84 TSHR (0.68) TSHRALDH1A1TAAR1AOC3HRH3
Ethyl Chloride SCHEMBL29003310 0.83 TSHR (0.81) TSHRALDH1A1TAAR1AOC3HRH3
Ethylene SCHEMBL28087838 0.83 TSHR (0.90) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL4868343 0.83 TSHR (0.90) TSHRALDH1A1TAAR1AOC3HRH3
Chloromethane SCHEMBL28157121 0.83 TSHR (0.90) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL24735547 0.82 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL5014268 0.82 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL27766437 0.82 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3
SCHEMBL15900 0.82 TSHR (1.00) TSHRALDH1A1TAAR1AOC3HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 455 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240216298-A1 TOPICAL TREATMENT OF HERPES INFECTIONS TECH SWERVE, LLC 2024-07-04 US claimed
US-11414953-B2 Method for killing oil and gas wells LIMITED LIABILITY COMPANY “GR PETROLEUM” (RU) 2022-08-16 US claimed
WO-2021015632-A1 COMPOSITION FOR CLEANING VEHICLE BODYWORK, RIMS, MOTORS AND ACCESSORIES WITHOUT DAMAGING THE PAINTWORK, AND PREPARATION METHOD QUISPE MUNIZ WILBER (PE) 2021-01-28 WO claimed
US-20210017832-A1 METHOD FOR KILLING OIL AND GAS WELLS LIMITED LIABILITY COMPANY "GR PETROLEUM" [RU/RU] (RU) 2021-01-21 US claimed
EP-3701942-A1 SOLUBILIZATION OF CHLORHEXIDINE BASE, ANITSEPTIC COMPOSITION AND DISINFECTANT COMPOSITION The Limited Liability Company "Sun Systems" (RU) 2020-09-02 EP claimed
US-20170258861-A1 Treatment of Herpes, Pseudomonas, Staph, and Hepatitis SQUIRES MERYL J (US) 2017-09-14 US claimed
US-9034352-B2 Microbicide combinations containing silver ROHM AND HAAS COMPANY (US) 2015-05-19 US claimed
EP-1941797-B1 Microbicide combinations containing silver ROHM & HAAS (US) 2010-06-02 EP claimed
US-20090191288-A1 Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases SQUIRES MERYL J 2009-07-30 US claimed
EP-1941797-A1 Microbicide combinations containing silver Rohm and Haas Company (US) 2008-07-09 EP claimed
EP-0918458-A1 ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES Squires, Meryl (US) 1999-06-02 EP claimed
WO-1998042188-A1 ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES SQUIRES MERYL (US) 1998-10-01 WO claimed
US-5811013-A Oil separating method FSK INC. (JP) 1998-09-22 US claimed
WO-1998011778-A1 ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES SQUIRES MERYL (US) 1998-03-26 WO claimed
EP-0505023-B1 Synergistic, additive or antagonistic product selection test for biocides NALCO CHEMICAL CO (US) 1996-08-21 EP claimed
US-5374536-A Adding known quantity of microbe contaminated water, nutrient, oxidation-reduction indicator to series of sample wells, adding serial dilution of first and second microbiocides, incubating, comparing color change NALCO CHEMICAL COMPANY (US) 1994-12-20 US claimed
US-5330674-A Mixing with alkylbenzyldimethylammonium chloride HENKEL CORPORATION (US) 1994-07-19 US claimed
EP-0505023-A1 Synergistic, additive or antagonistic product selection test for biocides NALCO CHEMICAL COMPANY (US) 1992-09-23 EP claimed
US-5010183-A Process for purifying DNA and RNA using cationic detergents QIAGEN N.V. (NL) 1991-04-23 US claimed
US-4069066-A AMINE COMPOUNDS, METAL SALT THE PROCTER & GAMBLE COMPANY (US) 1978-01-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170258861-A1 Treatment of Herpes, Pseudomonas, Staph, and Hepatitis NISCH, CUTA, HRH1 TSHR 4031/4885ALDH1A1 690/4885TAAR1 1226/4885
US-20090191288-A1 Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases ASPH, KCNH3, PRPH TSHR 3414/4885ALDH1A1 876/4885TAAR1 1198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.